During the past decade, Alzheimer's Research Corp./Merician Institute for Aging conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Alzheimer's Research Corp./Merician Institute for Aging" are "Alzheimer Disease" (2 trials). Many other conditions were trialed in "Alzheimer's Research Corp./Merician Institute for Aging" in a lesser frequency.

Most popular intervention types in "Alzheimer's Research Corp./Merician Institute for Aging" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bapineuzumab 0.5 mg/kg" (1 trials), "bapineuzumab" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alzheimer's Research Corp./Merician Institute for Aging" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Alzheimer's Research Corp./Merician Institute for Aging". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Alzheimer's Research Corp./Merician Institute for Aging, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Alzheimer's Research Corp./Merician Institute for Aging, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".